Tolerance Bio has finalized a high-stakes licensing agreement with Tanabe Pharma, acquiring exclusive worldwide commercialization rights—excluding Japan—for TLB-33, a clinical-stage…
Read More
Japan Ministry of Health Labour and Welfare Approves Viatris Wakix Pitolisant for Excessive Daytime Sleepiness and Narcolepsy
Viatris has secured a major regulatory milestone in East Asia as Japan’s Ministry of Health, Labour and Welfare (MHLW) officially…
Read More
Japan Emerges as a Global Powerhouse for Regenerative Medicine Innovation
Japan is rapidly solidifying its position as a premier destination for regenerative medicine research and development, a surge driven by…
Read More
Genetic Research Unveils Two Distinct Species of Leaf Warbler in Japan, Highlighting Hidden Biodiversity
The scientific community is abuzz with the recent confirmation of a previously unrecognized bird species in Japan, a groundbreaking discovery…
Read More
DNA Unveils a Hidden Avian Gem: Japan Welcomes a New Bird Species After Decades of Scientific Scrutiny
The quiet rustling of leaves in Japan’s remote island archipelagos has revealed a profound secret: a previously unrecognized bird species,…
Read More
Genetic Research Uncovers a New Bird Species in Japan: The Tokara Leaf Warbler
The discovery of a previously unrecognized bird species in Japan, the Tokara Leaf Warbler (Phylloscopus tokaraensis), highlights the crucial role…
Read More
Japan’s Pharmaceutical Market Embraces Speed and Execution Amidst Global Pressures
Japan’s pharmaceutical industry, the world’s third-largest by market value, is undergoing a significant and visible transformation. Historically characterized by methodical…
Read More
UK Secures Favipiravir Supply from Japan to Bolster Hantavirus Preparedness
The United Kingdom has received a crucial supply of the antiviral medication favipiravir from the Japanese government, a strategic move…
Read More
Japan Approves Jascayd (nerandomilast) for Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis
Boehringer Ingelheim has achieved a significant milestone in the treatment of interstitial lung diseases with the approval of Jascayd (nerandomilast)…
Read More
Japan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market Impact
Japan’s latest National Health Insurance (NHI) drug price revision for Fiscal Year 2026 (FY26) has officially taken effect, ushering in…
Read More
